title: Erlotinib in the treatment of patients with multiple metastases from non-small cell lung cancer: clinical case selection for optimal response.
authors.forename: R
authors.initials: R
authors.lastname: Davis
authors.forename: P
authors.initials: P
authors.lastname: Fenton
authors.forename: M
authors.initials: M
authors.lastname: Bayne
authors.forename: L
authors.initials: L
authors.lastname: Cherrett
authors.forename: V
authors.initials: V
authors.lastname: Laurence
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011799:Quinazolines / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D011799:Quinazolines; D000069347:Erlotinib Hydrochloride